Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 16, 2023

BUY
$254.9 - $283.59 $3,058 - $3,403
12 New
12 $3,000
Q1 2023

May 18, 2023

BUY
$229.71 - $259.35 $39,050 - $44,089
170 Added 17.17%
1,160 $287,000
Q4 2022

Feb 16, 2023

SELL
$218.29 - $256.91 $30,124 - $35,453
-138 Reduced 12.23%
990 $252,000
Q3 2022

Nov 16, 2022

BUY
$51.03 - $264.23 $7,807 - $40,427
153 Added 15.69%
1,128 $251,000
Q2 2022

Nov 15, 2022

SELL
$234.74 - $275.42 $70,187 - $82,350
-299 Reduced 23.47%
975 $240,000
Q1 2022

May 17, 2022

SELL
$243.64 - $270.48 $3.98 Million - $4.42 Million
-16,330 Reduced 92.76%
1,274 $339,000
Q4 2021

Feb 18, 2022

BUY
$230.08 - $250.94 $4.05 Million - $4.42 Million
17,604 New
17,604 $280,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Sky View Investment Advisors, LLC Portfolio

Follow Sky View Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sky View Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sky View Investment Advisors, LLC with notifications on news.